At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
WHITEHOUSE STATION, NJ - February 20, 2008 - Merck & Co., Inc. today announced plans to reduce greenhouse gas emissions from the Company's global operations by 12 percent by the end of 2012, using 2004 as its base year. The announcement was made as part of Merck's part...
WHITEHOUSE STATION, N.J. - November 19, 2007 - The Merck Company Foundation announced today a $2.8 million commitment to establish two new immunization training centers in Uganda and Zambia and to expand the Foundation's support of two existing centers in Kenya and Mali as p...
WHITEHOUSE STATION, NJ, USA, and QUITO, ECUADOR - November 15, 2007 - Public health officials gathering at the 17th Inter-American Conference on Onchocerciasis (IACO) in Quito, Ecuador, today announced that transmission of the tropical disease onchocerciasis (also known as r...
WHITEHOUSE STATION, N.J. - Aug. 20, 2007 - Merck & Co. Inc., today announced the winners of the first annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in medicinal or synth...
WASHINGTON, DC- May 31, 2007 "“ During the 34th Annual Global Health Conference Meeting here today Merck & Co., Inc.*, announced the release of the "Blueprint for Business Action on HIV/AIDS." The Blueprint is an innovative tool developed by a predominately...
The Bill & Melinda Gates Foundation, Merck & Co., Inc. and the Republic of Botswana today announced the establishment of the Botswana Comprehensive HIV/AIDS Partnership, a new initiative to improve the overall state of HIV/AIDS care and treatment in Botswana. In coll...